Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells202
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity169
Exploiting antifungal immunity in the clinical context87
Editorial Board72
Differential immune responses behind different celiac disease manifestations67
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity65
Cellular stress and macrophage activation65
Editorial Board65
Aging of lymphoid stromal architecture impacts immune responses57
Microbial metabolites and immunotherapy: Basic rationale and clinical indications55
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi54
Resolving inflammatory links between myocardial infarction and vascular dementia52
Pyroptosis modulation by bacterial effector proteins49
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges48
Local and Cell-intrinsic complement: The new player in cancer progression48
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity47
Immunity to pathogenic fungi in the eye46
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)42
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?41
The noncanonical inflammasome-induced pyroptosis and septic shock41
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease39
Pyroptosis: A road to next-generation cancer immunotherapy38
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity37
Pyroptosis and the cellular consequences of gasdermin pores36
Interplay between the complement system and other immune pathways in the tumor microenvironment34
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment33
Western diet influences on microbiome and carcinogenesis33
Specialized pro-resolving mediators as modulators of immune responses32
Autoimmune diabetes and targets for immunomodulation29
Neuroimmune interactions between itch neurons and skin microbes29
Cellular and molecular diversity in spondyloarthritis28
The evolving biology of cross-presentation28
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets28
Immunity to fungi: Editorial overview28
The paradox of aging: Aging-related shifts in T cell function and metabolism27
Adaptive NK cell response to human cytomegalovirus: Facts and open issues26
Thymus aging and immune reconstitution, progresses and challenges26
TREM2: A new player in the tumor microenvironment26
Sialic acid and Siglec receptors in tumor immunity and immunotherapy24
Antigen discovery for the development of cancer immunotherapy24
Recent developments in C3-targeted complement therapeutics23
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs22
T cell control of SARS-CoV-2: When, which, and where?22
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases22
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination22
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy22
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases22
Introduction to the Special Issue: Nutrition, microbiota and immunity21
Targeting the tissue-complosome for curbing inflammatory disease21
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic21
T cell fate decisions during memory cell generation with aging20
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy19
The glycoimmune landscape in health and disease19
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?19
Editorial Board19
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity19
Better safe than sorry: Naive T-cell dynamics in healthy ageing18
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis18
Proteostasis in T cell aging18
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy18
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells18
Global aspects of celiac disease and food allergy17
Natural killer cell responses to human oncogenic γ-herpesvirus infections17
Publisher's note: Welcome Prof. Guido Kroemer17
Harnessing complement biomarkers for precision cancer care17
Cellular and molecular heterogeneity in systemic lupus erythematosus17
The complement system in clinical oncology: Applications, limitations and challenges17
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice17
Emerging opportunities for C3 inhibition in the eye16
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review16
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions15
Identification of T cell antigens in the 21st century, as difficult as ever15
Epigenetic and transcriptional control of gasdermins15
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging15
The gut-enthesis axis and the pathogenesis of Spondyloarthritis15
The multisensory regulation of unconventional T cell homeostasis15
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches14
A major mechanism for immunomodulation: Dietary fibres and acid metabolites14
Siglecs as modulators of macrophage phenotype and function14
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics14
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond14
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation14
Corrigendum to “Nanoalum adjuvanted vaccines: Small details make a big difference” [Semin. Immunol. 56 (2021) 101544]14
Human thymus in health and disease: Recent advances in diagnosis and biology14
Unconventional protein secretion by gasdermin pores14
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases13
Durability of immune responses to SARS-CoV-2 infection and vaccination13
The role of ILC subsets in cancer13
Reparative inflammation in multiple sclerosis12
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC12
Pyroptosis-induced inflammation and tissue damage12
Systems analysis of innate and adaptive immunity in Long COVID12
Microbial gasdermins: More than a billion years of pyroptotic-like cell death12
Integrating immunopeptidome analysis for the design and development of cancer vaccines11
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation11
Galectins and Host–Pathogen Interactions: The roles in viral infections11
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data11
The gut-brain vascular axis in neuroinflammation11
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas11
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease11
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions11
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies11
Regulatory T cells in allergic inflammation10
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences10
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond10
Complement regulation in tumor immune evasion10
Systems analysis of human innate immunity in COVID-1910
Editorial Board10
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function10
Publisher’s Note: A change in leadership10
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives9
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies9
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging9
Complement component C3: A structural perspective and potential therapeutic implications9
Editorial Board9
Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions9
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging9
Editorial Board9
To die or not to die: Gasdermins in intestinal health and disease9
The role of sialoglycans in modulating dendritic cell function and tumour immunity9
Immunity to fungi in the lung9
The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients9
The origins, manifestations, and potential treatments of allergic disorders9
0.12037301063538